Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 25 02:45PM ET
16.83
Dollar change
-1.01
Percentage change
-5.66
%
IndexRUT P/E- EPS (ttm)-3.25 Insider Own20.88% Shs Outstand32.42M Perf Week-3.11%
Market Cap545.63M Forward P/E- EPS next Y-2.78 Insider Trans59.96% Shs Float25.65M Perf Month18.19%
Income-80.33M PEG- EPS next Q-0.72 Inst Own70.01% Short Float1.54% Perf Quarter26.64%
Sales0.00M P/S- EPS this Y13.20% Inst Trans-0.43% Short Ratio6.05 Perf Half Y148.96%
Book/sh5.53 P/B3.05 EPS next Y2.92% ROA-39.37% Short Interest0.39M Perf Year67.13%
Cash/sh5.40 P/C3.11 EPS next 5Y- ROE-46.72% 52W Range3.72 - 18.72 Perf YTD147.50%
Dividend Est.- P/FCF- EPS past 5Y-172.30% ROI-41.04% 52W High-10.10% Beta1.77
Dividend TTM- Quick Ratio15.78 Sales past 5Y0.00% Gross Margin- 52W Low352.42% ATR (14)1.19
Dividend Ex-Date- Current Ratio15.78 EPS Y/Y TTM2.65% Oper. Margin0.00% RSI (14)53.76 Volatility6.43% 8.21%
Employees64 Debt/Eq0.11 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price21.60
Option/ShortNo / Yes LT Debt/Eq0.09 EPS Q/Q8.44% Payout- Rel Volume0.97 Prev Close17.84
Sales Surprise- EPS Surprise18.85% Sales Q/Q- EarningsMay 14 AMC Avg Volume65.16K Price16.83
SMA200.02% SMA5015.92% SMA20068.45% Trades Volume51,614 Change-5.66%
Date Action Analyst Rating Change Price Target Change
Dec-21-22Initiated H.C. Wainwright Buy $26
Jun-11-24 07:00AM
May-15-24 01:20PM
May-14-24 10:55PM
04:02PM
Apr-12-24 01:30PM
04:05PM Loading…
Mar-13-24 04:05PM
07:00AM
Mar-12-24 09:55AM
Mar-11-24 12:00PM
Mar-06-24 11:54PM
04:01PM
Mar-04-24 07:00AM
Feb-29-24 03:02AM
Feb-20-24 08:00AM
Feb-07-24 07:30AM
07:00AM Loading…
Jan-17-24 07:00AM
Jan-08-24 07:00AM
Dec-18-23 08:00AM
Nov-15-23 08:00AM
Nov-08-23 08:00AM
Oct-12-23 07:00AM
Sep-27-23 04:16PM
Sep-06-23 04:05PM
08:00AM
Sep-01-23 08:00AM
Aug-08-23 08:15AM
Jun-13-23 04:05PM
May-31-23 11:44AM
May-30-23 04:05PM
May-18-23 07:00AM
07:00AM Loading…
May-11-23 07:00AM
May-04-23 08:00AM
Apr-17-23 08:00AM
Apr-13-23 04:05PM
Mar-27-23 02:25AM
Mar-23-23 04:05PM
Mar-22-23 08:00AM
Mar-21-23 04:05PM
Mar-16-23 08:00AM
Mar-13-23 08:00AM
Feb-27-23 08:50AM
Feb-09-23 08:00AM
Jan-31-23 08:50AM
Jan-16-23 05:10AM
Jan-13-23 08:50AM
Dec-21-22 02:25PM
Dec-07-22 08:00AM
Dec-01-22 09:55AM
Nov-21-22 08:50AM
Nov-15-22 09:55AM
Nov-14-22 08:00AM
Nov-10-22 08:00AM
Nov-08-22 08:00AM
Oct-13-22 01:00PM
Sep-28-22 01:59PM
09:25AM
06:00AM
Sep-22-22 08:00AM
Sep-04-22 07:17AM
Aug-12-22 08:00AM
Aug-08-22 10:51AM
Jul-22-22 07:45AM
Jun-16-22 08:30AM
May-27-22 05:22PM
May-05-22 11:34PM
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mellion Michelle LChief Medical OfficerJun 12 '24Option Exercise10.211,08611,0881,086Jun 13 04:46 PM
Mellion Michelle LChief Medical OfficerJun 12 '24Sale18.061,08619,6150Jun 13 04:46 PM
Mellion Michelle LChief Medical OfficerJun 11 '24Option Exercise10.215005,105500Jun 13 04:46 PM
Mellion Michelle LChief Medical OfficerJun 11 '24Sale18.045009,0220Jun 13 04:46 PM
Mellion Michelle LSVP, Clinical DevelopmentJun 06 '24Option Exercise10.211,41114,4061,411Jun 07 04:12 PM
Mellion Michelle LSVP, Clinical DevelopmentJun 06 '24Sale18.001,41125,3980Jun 07 04:12 PM
Mellion Michelle LSVP, Clinical DevelopmentJun 05 '24Option Exercise10.217,24573,9717,245Jun 07 04:12 PM
Mellion Michelle LSVP, Clinical DevelopmentJun 05 '24Sale18.097,245131,0620Jun 07 04:12 PM
Svenstrup NielsSVP, Chem. Mfg & ControlsMay 17 '24Sale13.4110,000134,1000May 17 08:51 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 09 '24Buy10.642,557,59327,212,7909,179,273Feb 13 04:33 PM
McArthur James GPresident and CEONov 30 '23Buy4.171,6947,0561,694Dec 05 07:34 AM